Institut Toulousain des Maladies Infectieuses et Inflammatoires
  • News
    • Publications
    • Seminars
    • Thesis and Authorized to Steer Researches Defense
    • Highlights
  • The Institute
    • Education
    • Organization chart
    • Join us
    • Financing partners
    • Directory
  • Research Teams
    • J.C. Guéry
    • M. Simon
    • N. Gaudenzio
    • R. Liblau / A. Saoudi
    • J. Ausseil / R. Poupot
    • N. Blanchard
    • D. Dunia / C. Malnou
    • J. Izopet / B. Lagane
    • N. Jabrane-Ferrat
    • J. van Meerwijk / O. Joffre
    • N. Fazilleau / S. Guerder
    • R. Lesourne / L. Dupré
    • M. Diaz Munoz
    • L. Reber
    • C. Le Coz
    • A. Dejean
  • Technical Platforms
    • Cell Imaging
    • Cytometry & Cell Sorting
    • Human immune-monitoring
    • Genomic and transcriptomic
  • Contact
  • Français
Select Page
Heterochromatic gene silencing controls CD4+ T cell susceptibility to regulatory T cell-mediated suppression in a murine allograft model

Heterochromatic gene silencing controls CD4+ T cell susceptibility to regulatory T cell-mediated suppression in a murine allograft model

21 Jan 2025 | Publications

  Authors : Julie Noguerol, Karl Laviolette, Margot Zahm, Adeline Chaubet, Ambrine Sahal, Claire Détraves, Romain Torres, Clothilde Demont, Véronique Adoue, Carine Joffre , Florence Cammas, Joost PM van Meerwijk & Olivier P. Joffre DOI :...
Landscape of Mast Cell Populations across Organs in Mice and Humans

Landscape of Mast Cell Populations across Organs in Mice and Humans

22 Sep 2023 | Publications

The research team of Nicolas Gaudenzio at Infinity has recently published a new article titled “Landscape of Mast Cell Populations across Organs in Mice and Humans” in The Journal of Experimental Medicine. This pioneering study stands as the very first...
3D deconvolution of human skin immune architecture with Multiplex Annotated Tissue Imaging System

3D deconvolution of human skin immune architecture with Multiplex Annotated Tissue Imaging System

22 Sep 2023 | Publications

The research team led by Nicolas Gaudenzio at Infinity proudly presents, in collaboration with Genoskin, their latest innovation , the Multiplex Annotated Tissue Imaging System, which has just been published in Science Advances. In their publication, they showcase...
Human Cytomegalovirus Modifies Placental Small Extracellular Vesicle Composition to Enhance Infection of Fetal Neural Cells In Vitro

Human Cytomegalovirus Modifies Placental Small Extracellular Vesicle Composition to Enhance Infection of Fetal Neural Cells In Vitro

27 Sep 2022 | Publications

Human Cytomegalovirus Modifies Placental Small Extracellular Vesicle Composition to Enhance Infection of Fetal Neural Cells In Vitro Mathilde Bergamelli, Hélène Martin, Yann Aubert, Jean-Michel Mansuy, Marlène Marcellin, Odile Burlet-Schiltz, Ilse Hurbain,Graça...
HIV-1 cell-to-cell spread overcomes the virus entry block of non-macrophage-tropic strains in macrophages

HIV-1 cell-to-cell spread overcomes the virus entry block of non-macrophage-tropic strains in macrophages

17 Jun 2022 | Publications

HIV-1 cell-to-cell spread overcomes the virus entry block of non-macrophage-tropic strains in macrophages. Mingyu Han, Vincent Cantaloube-Ferrieu, Maorong Xie, Marie Armani-Tourret,Marie Woottum, Jean-Christophe Pagès, Philippe Colin, Bernard Lagane*, Serge Benichou*...
The anti-FcepsilonRI antibody MAR-1 depletes basophils and cross-reacts with myeloid cells through its Fc portion

The anti-FcepsilonRI antibody MAR-1 depletes basophils and cross-reacts with myeloid cells through its Fc portion

2 May 2022 | Publications

The anti-FcepsilonRI antibody MAR-1 depletes basophils and cross-reacts with myeloid cells through its Fc portion. Worrall WPM*, Kamphuis JBJ*, Stackowicz J, Mougel A, Maure E, Pecalvel C, et al Allergy. 2022; 00:1–4. MAR-1 is the only monoclonal antibody used to...
« Older Entries
Next Entries »
Crédits et mentions légales - © Agences CosiWeb & ComScience
Nous utilisons des cookies pour vous garantir la meilleure expérience sur notre site. Si vous continuez à utiliser ce dernier, nous considérerons que vous acceptez l'utilisation des cookies.OkEn savoir plus